Update on the diagnosis and management of acute kidney injury
- PMID: 21694939
- PMCID: PMC3108768
- DOI: 10.2147/IJNRD.S8641
Update on the diagnosis and management of acute kidney injury
Abstract
Acute kidney injury (AKI) is an independent risk factor for morbidity and mortality. This review provides essential information for the diagnosis and management of AKI. Blood urea nitrogen and serum creatinine are used for the diagnosis of AKI. The review also focuses on recent studies on the diagnosis of AKI using the RIFLE (R-renal risk, I-injury, F-failure, L-loss of kidney function, E-end stage kidney disease) and Acute Kidney Injury Network criteria, and serum and urine AKI biomarkers. Dialysis is the only Food and Drug Administration-approved therapy for AKI. Recent studies on the dose of dialysis in AKI are reviewed.
Keywords: acute kidney injury; biomarkers; interleukin-18.
2010 Halvorson et al, publisher and licensee Dove Medical Press Ltd.
References
-
- Lassnigg A, Schmidlin D, Mouhieddine M, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15(6):1597–1605. - PubMed
-
- Van Biesen W, Vanholder R, Lameire N. Defining acute renal failure: RIFLE and beyond. Clin J Am Soc Nephrol. 2006;1(6):1314–1319. - PubMed
-
- Bellomo R, Kellum JA, Ronco C. Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med. 2007;33(3):409–413. - PubMed
-
- Waikar SS, Liu KD, Chertow GM. Diagnosis, epidemiology, and outcomes of acute renal failure. Clin J Am Soc Nephrol. 2008;3(3):844–861. - PubMed
-
- Haase M, Bellomo R, Matalanis G, Calzavacca P, Dragun D, Haase-Fielitz A. A comparison of the RIFLE and Acute Kidney Injury Network classifications for cardiac surgery-associated acute kidney injury: a prospective cohort study. J Thorac Cardiovasc Surg. 2009;138(6):1370–1376. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
